Literature DB >> 5309633

Anti HL-A2 inhibitor in normal human serum.

J J van Rood, A van Leeuwen, M C van Santen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5309633     DOI： 10.1038/226366a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  31 in total

1.  Inhibition of Epstein-Barr virus (EBV)-specific CD8+ cytotoxic T lymphocyte (CTL) activity by soluble HLA class I in vitro.

Authors:  B Gansuvd; M Hagihara; B Munkhbat; N Kanai; N Morita; N Munkhtuvshin; J Chargui; S Kato; T Hotta; K Tsuji
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

2.  Soluble beta2-mu-associated and beta2-mu-free HLA class I heavy chain serum levels in interferon-alpha nonresponder chronic hepatitis C patients. Markers of immune activation, and response to antiviral retreatment.

Authors:  F Puppo; F Torre; P Contini; M Ghio; S Brenci; R Brizzolara; N Sinelli; N Campo; F Indiveri; A Picciotto
Journal:  J Clin Immunol       Date:  2000-11       Impact factor: 8.317

3.  Examination of serum class I antigen in liver-transplanted rats.

Authors:  R Sumimoto; T Shinomiya
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

4.  Soluble class I histocompatibility antigens (s-HLA) and beta 2-microglobulin at delivery.

Authors:  A Ferreira; M C García Rodríguez; F Omeñaca; A Jiménez; L M Villar; P Gonzalez-Porqué; G Fontán
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

5.  Mining the plasma immunopeptidome for cancer peptides as biomarkers and beyond.

Authors:  Heather D Hickman; Jonathan W Yewdell
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

6.  Quantification of soluble HLA class I gene products by an enzyme linked immunosorbent assay.

Authors:  I Doxiadis; U Westhoff; H Grosse-Wilde
Journal:  Blut       Date:  1989-11

7.  Identification, characterization, and quantitation of soluble HLA antigens in the circulation and peritoneal dialysate of renal patients.

Authors:  F B Gelder; J C McDonald; M D Landreneau; R M McMillan; D F Aultman
Journal:  Ann Surg       Date:  1991-06       Impact factor: 12.969

Review 8.  Mouse models in bone marrow transplantation and adoptive cellular therapy.

Authors:  Caroline Arber; Malcolm K Brenner; Pavan Reddy
Journal:  Semin Hematol       Date:  2013-06-11       Impact factor: 3.851

9.  Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma.

Authors:  Bracha Shraibman; Eilon Barnea; Dganit Melamed Kadosh; Yael Haimovich; Gleb Slobodin; Itzhak Rosner; Carlos López-Larrea; Norbert Hilf; Sabrina Kuttruff; Colette Song; Cedrik Britten; John Castle; Sebastian Kreiter; Katrin Frenzel; Marcos Tatagiba; Ghazaleh Tabatabai; Pierre-Yves Dietrich; Valérie Dutoit; Wolfgang Wick; Michael Platten; Frank Winkler; Andreas von Deimling; Judith Kroep; Juan Sahuquillo; Francisco Martinez-Ricarte; Jordi Rodon; Ulrik Lassen; Christian Ottensmeier; Sjoerd H van der Burg; Per Thor Straten; Hans Skovgaard Poulsen; Berta Ponsati; Hideho Okada; Hans-Georg Rammensee; Ugur Sahin; Harpreet Singh; Arie Admon
Journal:  Mol Cell Proteomics       Date:  2018-08-02       Impact factor: 5.911

10.  Reexposure of cord blood to noninherited maternal HLA antigens improves transplant outcome in hematological malignancies.

Authors:  Jon J van Rood; Cladd E Stevens; Jacqueline Smits; Carmelita Carrier; Carol Carpenter; Andromachi Scaradavou
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-09       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.